骨肉腫治療の世界市場規模調査・予測：タイプ別、薬剤タイプ別、流通チャネル別、地域別分析、2022-2029年

骨肉腫治療の世界市場は、2021年に約12億米ドルと評価され、予測期間2022-2029年には4.5%以上の健全な成長率で成長すると予想されています。

骨肉腫は、骨を侵すまれな病気です。骨から始まり、体の他の部位に転移し、正常な骨組織を損傷することがあります。骨肉腫は、新しい骨組織が形成される細胞で発生する最も一般的なタイプの骨肉腫と考えられています。骨肉腫の治療法には、手術、放射線療法、化学療法などがあります。骨肉腫の有病率の増加や新興国市場におけるがん治療サービスの浸透、主要企業の戦略的取り組みなどが、市場成長を加速させる主な要因となっています。

骨肉腫の発生率の増加は、世界の骨肉腫治療市場の成長に寄与しています。例えば、米国がん協会の推計によると、2022年には米国で約3910件の骨肉腫の新規症例が報告され、一方、約2100人の子供と大人が骨肉腫によって命を落としています。また、小児および10代に最も多く見られるがんの種類は、骨肉腫で56％の有病率、次いでユーイング腫瘍（34％）、軟骨肉腫（6％）であることが分かっています。また、政府の取り組みや償還政策の拡大、新興国市場の医療インフラ整備が進んでいることも、予測期間中の市場の有利な成長見通しを生み出しています。しかし、高い治療費が2022年から2029年の予測期間を通じて市場の成長を阻害します。

世界の骨肉腫治療市場の調査において考慮された主要地域は、アジア太平洋、北米、欧州、中南米、世界のその他の地域です。北米は収益面で市場を独占しており、これは同地域における主要な市場プレイヤーの優位性と骨肉腫治療における技術的進歩の増加によるものです。一方、アジア太平洋地域は、予測期間中に最も高いCAGRで成長すると予想されています。これは、老年人口および対象人口の増加、医療インフラに対する政府支出の増加、地域におけるがん治療センターの出現の増加といった要因によるものです。

本調査の目的は、近年におけるさまざまなセグメントおよび国の市場規模を明らかにし、今後数年間の市場規模を予測することです。本レポートは、調査対象国における産業の質的・量的な側面を取り入れるよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題などの重要な側面に関する詳細な情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場の潜在的な機会も組み込んでいます。

タイプ別

骨肉腫

軟骨肉腫

ユーイング肉腫

薬剤タイプ別

免疫療法・標的療法

化学療法

販売チャネル別

病院薬局

ドラッグストア・小売店

オンライン薬局

目次

第1章 エグゼクティブサマリー

• 市場スナップショット
• 世界・セグメント別市場推定・予測、2019年～2029年
  • 骨肉腫治療市場：地域別、2019-2029年
  • 骨肉腫治療市場：タイプ別、2019-2029年
  • 骨肉腫治療市場：薬物タイプ別、2019-2029年
  • 骨肉腫治療市場：流通チャネル別、2019年～2029年
• 主な動向
• 調査手法
• 調査前提条件

第2章 骨肉腫治療の世界市場の定義と範囲

• 調査の目的
• 市場の定義と範囲
  • 本調査の対象範囲
  • 産業の進化
• 調査対象年
• 通貨換算レート

第3章 骨肉腫治療の世界市場力学

• 骨肉腫治療市場のインパクト分析（2019-2029年）
  • 市場促進要因
    • 骨肉腫の有病率の増加
    • 発展途上地域におけるがん治療サービスの浸透の高まり
    • 主要な市場プレイヤーの戦略的な取り組み
  • 市場の課題
    • 骨肉腫の治療費用の高さ
  • 市場機会
    • 有利な政府の取り組みと償還政策
    • 発展途上地域におけるヘルスケアインフラの増加

第4章 骨肉腫治療の世界市場産業分析

• ポーターの5フォースモデル
  • 供給企業の交渉力
  • 買い手の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争企業間の敵対関係
• ポーターの5フォースモデルへの未来的アプローチ（2019-2029年）
• PEST分析
  • 政治的
  • 経済的
  • 社会的
  • 技術的
• トップ投資機会
• 主要成功戦略
• 業界専門家別展望
• アナリストの結論・提言

第5章 リスク評価：COVID-19のインパクト

• COVID-19が業界に与える全体的な影響の評価
• COVID-19以前とCOVID-19以後の市場シナリオ

第6章 骨肉腫治療の世界市場：タイプ別

• 市場スナップショット
• 骨肉腫治療の世界市場：タイプ別実績-ポテンシャル分析
• 骨肉腫治療の世界市場タイプ別推定・予測2019-2029
• 骨肉腫治療市場、サブセグメント分析
  • 骨肉腫（Osteosarcoma
  • 軟骨肉腫（コンドロサルコーマ
  • ユーイング肉腫

第7章：骨肉腫治療薬の世界市場、薬剤タイプ別

• 市場スナップショット
• 骨肉腫治療の世界市場：薬剤タイプ別実績-ポテンシャル分析
• 骨肉腫治療の世界市場、薬剤タイプ別推定・予測（2019-2029年
• 骨肉腫治療市場、サブセグメント分析
  • 免疫療法と標的療法
  • 化学療法

第8章 骨肉腫治療の世界市場：流通チャネル別

• 市場スナップショット
• 骨肉腫治療の世界市場、流通チャネル別実績-ポテンシャル分析
• 骨肉腫治療の世界市場、流通チャネル別推定・予測（2019-2029年
• 骨肉腫治療市場、サブセグメント分析
  • 病院内薬局
  • ドラッグストアと小売薬局
  • オンライン薬局

第9章 骨肉腫治療薬の世界市場：地域別分析

• 骨肉腫治療市場、地域別市場スナップショット
• 北米
  • 米国
    • タイプ別推定・予測、2019-2029年
    • 薬剤タイプ別の推定・予測、2019年～2029年
    • 流通チャネル別の推定・予測、2019年～2029年
  • カナダ
• 欧州骨肉腫治療市場スナップショット
  • 英国
  • ドイツ
  • フランス
  • スペイン
  • イタリア
  • その他の欧州地域
• アジア太平洋地域の骨肉腫治療市場のスナップショット
  • 中国
  • インド
  • 日本
  • オーストラリア
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカの骨肉腫治療市場のスナップショット
  • ブラジル
  • メキシコ
  • その他のラテンアメリカ地域
• 世界のその他の地域

第10章 競合情報

• トップ市場戦略
• 企業プロファイル
  • Advaxis Inc.
    • 主要情報
    • 概要
    • 財務情報（データの入手状況により異なります）
    • 製品概要
    • 最近の動向
  • Takeda Pharmaceutical Company Limited
  • Cancervax, Inc
  • Cellectar Biosciences, Inc
  • Pfizer, Inc
  • Isofol Medical Ab
  • Gradalis Inc
  • Hikma Pharmaceutical PLC
  • QSAM Biosciences, Inc.
  • Zentalis Pharmaceuticals

第11章 調査プロセス

• 調査プロセス
  • データマイニング
  • 分析
  • 市場推定
  • バリデーション
  • 出版
• 調査属性
• 調査の前提条件

LIST OF TABLES

• TABLE 1. Global Bone Cancer Treatment Market, report scope
• TABLE 2. Global Bone Cancer Treatment Market estimates & forecasts by Region 2019-2029 (USD Billion)
• TABLE 3. Global Bone Cancer Treatment Market estimates & forecasts by Type 2019-2029 (USD Billion)
• TABLE 4. Global Bone Cancer Treatment Market estimates & forecasts by Drug Type 2019-2029 (USD Billion)
• TABLE 5. Global Bone Cancer Treatment Market estimates & forecasts by Distribution Channel 2019-2029 (USD Billion)
• TABLE 6. Global Bone Cancer Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 7. Global Bone Cancer Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 8. Global Bone Cancer Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 9. Global Bone Cancer Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 10. Global Bone Cancer Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 11. Global Bone Cancer Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 12. Global Bone Cancer Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 13. Global Bone Cancer Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 14. Global Bone Cancer Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 15. Global Bone Cancer Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 16. U.S. Bone Cancer Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 17. U.S. Bone Cancer Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 18. U.S. Bone Cancer Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 19. Canada Bone Cancer Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 20. Canada Bone Cancer Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 21. Canada Bone Cancer Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 22. UK Bone Cancer Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 23. UK Bone Cancer Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 24. UK Bone Cancer Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 25. Germany Bone Cancer Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 26. Germany Bone Cancer Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 27. Germany Bone Cancer Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 28. France Bone Cancer Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 29. France Bone Cancer Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 30. France Bone Cancer Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 31. Italy Bone Cancer Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 32. Italy Bone Cancer Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 33. Italy Bone Cancer Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 34. Spain Bone Cancer Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 35. Spain Bone Cancer Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 36. Spain Bone Cancer Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 37. RoE Bone Cancer Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 38. RoE Bone Cancer Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 39. RoE Bone Cancer Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 40. China Bone Cancer Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 41. China Bone Cancer Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 42. China Bone Cancer Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 43. India Bone Cancer Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 44. India Bone Cancer Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 45. India Bone Cancer Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 46. Japan Bone Cancer Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 47. Japan Bone Cancer Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 48. Japan Bone Cancer Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 49. South Korea Bone Cancer Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 50. South Korea Bone Cancer Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 51. South Korea Bone Cancer Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 52. Australia Bone Cancer Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 53. Australia Bone Cancer Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 54. Australia Bone Cancer Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 55. RoAPAC Bone Cancer Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 56. RoAPAC Bone Cancer Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 57. RoAPAC Bone Cancer Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 58. Brazil Bone Cancer Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 59. Brazil Bone Cancer Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 60. Brazil Bone Cancer Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 61. Mexico Bone Cancer Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 62. Mexico Bone Cancer Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 63. Mexico Bone Cancer Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 64. RoLA Bone Cancer Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 65. RoLA Bone Cancer Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 66. RoLA Bone Cancer Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 67. Row Bone Cancer Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 68. Row Bone Cancer Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 69. Row Bone Cancer Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 70. List of secondary sources, used in the study of global Bone Cancer Treatment Market
• TABLE 71. List of primary sources, used in the study of global Bone Cancer Treatment Market
• TABLE 72. Years considered for the study
• TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

• FIG 1. Global Bone Cancer Treatment Market, research methodology
• FIG 2. Global Bone Cancer Treatment Market, Market estimation techniques
• FIG 3. Global Market size estimates & forecast methods
• FIG 4. Global Bone Cancer Treatment Market, key trends 2021
• FIG 5. Global Bone Cancer Treatment Market, growth prospects 2022-2029
• FIG 6. Global Bone Cancer Treatment Market, porters 5 force model
• FIG 7. Global Bone Cancer Treatment Market, pest analysis
• FIG 8. Global Bone Cancer Treatment Market, value chain analysis
• FIG 9. Global Bone Cancer Treatment Market by segment, 2019 & 2029 (USD Billion)
• FIG 10. Global Bone Cancer Treatment Market by segment, 2019 & 2029 (USD Billion)
• FIG 11. Global Bone Cancer Treatment Market by segment, 2019 & 2029 (USD Billion)
• FIG 12. Global Bone Cancer Treatment Market by segment, 2019 & 2029 (USD Billion)
• FIG 13. Global Bone Cancer Treatment Market by segment, 2019 & 2029 (USD Billion)
• FIG 14. Global Bone Cancer Treatment Market, regional snapshot 2019 & 2029
• FIG 15. North America Bone Cancer Treatment Market 2019 & 2029 (USD Billion)
• FIG 16. Europe Bone Cancer Treatment Market 2019 & 2029 (USD Billion)
• FIG 17. Asia Pacific Bone Cancer Treatment Market 2019 & 2029 (USD Billion)
• FIG 18. Latin America Bone Cancer Treatment Market 2019 & 2029 (USD Billion)
• FIG 19. Global Bone Cancer Treatment Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

Global Bone Cancer Treatment Market is valued at approximately USD 1.2 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 4.5% over the forecast period 2022-2029. Bone Cancer is a rare disease that affects bones. It begins with bones and can spread to other parts of the body and damages normal bone tissues. Osteosarcoma is considered the most common type of bone cancer that develops in the cells where new bone tissue forms. There are different treatment methods for bone cancer which include surgery, radiation therapy and chemotherapy. The increasing prevalence of bone cancer and growing penetration of cancer care services in developing regions as well as strategic initiatives from leading market players are key factors accelerating the market growth.

The increasing incidences of bone cancers are contributing to the growth of the Global Bone Cancer Treatment Market. For instance, according to American Cancer Society's estimates- in 2022, around 3910 new cases of bone cancer were reported in the United States, whereas approximately 2100 children & adults lost their lives due to bone cancer. Moreover, the most prevalent types of cancer in children and teens are Osteosarcoma with 56% prevalence, followed by Ewing tumors (34%), and Chondrosarcoma (6%). Also, growing government initiatives & reimbursement policies and rising healthcare infrastructure in developing regions would create a lucrative growth prospectus for the market over the forecast period. However, high treatment cost stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Bone Cancer Treatment Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the dominance of leading market players and increasing technological advancements in bone cancer treatment in the region. Whereas Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as rising geriatric and target populations, increasing government spending on healthcare infrastructure and rising emergence of cancer care centers in the region.

Major market players included in this report are:

Advaxis Inc.

Takeda Pharmaceutical Company Limited

Cancervax, Inc

Cellectar Biosciences, Inc

Pfizer, Inc

Isofol Medical Ab

Gradalis Inc

Hikma Pharmaceutical PLC

QSAM Biosciences, Inc.

Zentalis Pharmaceuticals

Recent Developments in the Market:

• In February 2022, CTI BioPharma Corp (CTIC.O) received approval for its drug for treating adult patients with bone marrow cancer from the U.S. Food and Drug Administration. Moreover, the new drug Vonjo (pacritinib), belongs to a class of anti-inflammatory treatments known as JAK inhibitors.

Global Bone Cancer Treatment Market Report Scope:

Historical Data: 2019-2020-2021

Base Year for Estimation: 2021

Forecast period: 2022-2029

Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends

Segments Covered: Type, Drug Type, Distribution Channel, Region

Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World

Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type

Osteosarcoma

Chondrosarcoma

Ewing Sarcoma

By Drug Type

Immunotherapy and Targeted Therapy

Chemotherapy

By Distribution Channel

Hospital Pharmacies

Drug Stores and Retail Pharmacies

Online Pharmacies

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

RoLA

Rest of the World

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
  • 1.2.1. Bone Cancer Treatment Market, by Region, 2019-2029 (USD Billion)
  • 1.2.2. Bone Cancer Treatment Market, by Type, 2019-2029 (USD Billion)
  • 1.2.3. Bone Cancer Treatment Market, by Drug Type, 2019-2029 (USD Billion)
  • 1.2.4. Bone Cancer Treatment Market, by Distribution Channel, 2019-2029 (USD Billion)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Bone Cancer Treatment Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Scope of the Study
  • 2.2.2. Industry Evolution
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Bone Cancer Treatment Market Dynamics

• 3.1. Bone Cancer Treatment Market Impact Analysis (2019-2029)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Increasing prevalence of bone cancer
    • 3.1.1.2. Growing penetration of cancer care services in developing regions
    • 3.1.1.3. Strategic initiatives from leading market players
  • 3.1.2. Market Challenges
    • 3.1.2.1. High Cost of Bone Cancer Treatment
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Favourable government initiatives & reimbursement policies
    • 3.1.3.2. Rising healthcare infrastructure in developing regions

Chapter 4. Global Bone Cancer Treatment Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
• 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
• 4.3. PEST Analysis
  • 4.3.1. Political
  • 4.3.2. Economical
  • 4.3.3. Social
  • 4.3.4. Technological
• 4.4. Top investment opportunity
• 4.5. Top winning strategies
• 4.6. Industry Experts Prospective
• 4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

• 5.1. Assessment of the overall impact of COVID-19 on the industry
• 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Bone Cancer Treatment Market, by Type

• 6.1. Market Snapshot
• 6.2. Global Bone Cancer Treatment Market by Type, Performance - Potential Analysis
• 6.3. Global Bone Cancer Treatment Market Estimates & Forecasts by Type 2019-2029 (USD Billion)
• 6.4. Bone Cancer Treatment Market, Sub Segment Analysis
  • 6.4.1. Osteosarcoma
  • 6.4.2. Chondrosarcoma
  • 6.4.3. Ewing Sarcoma

Chapter 7. Global Bone Cancer Treatment Market, by Drug Type

• 7.1. Market Snapshot
• 7.2. Global Bone Cancer Treatment Market by Drug Type, Performance - Potential Analysis
• 7.3. Global Bone Cancer Treatment Market Estimates & Forecasts by Drug Type 2019-2029 (USD Billion)
• 7.4. Bone Cancer Treatment Market, Sub Segment Analysis
  • 7.4.1. Immunotherapy and Targeted Therapy
  • 7.4.2. Chemotherapy

Chapter 8. Global Bone Cancer Treatment Market, by Distribution Channel

• 8.1. Market Snapshot
• 8.2. Global Bone Cancer Treatment Market by Distribution Channel, Performance - Potential Analysis
• 8.3. Global Bone Cancer Treatment Market Estimates & Forecasts by Distribution Channel 2019-2029 (USD Billion)
• 8.4. Bone Cancer Treatment Market, Sub Segment Analysis
  • 8.4.1. Hospital Pharmacies
  • 8.4.2. Drug Stores and Retail Pharmacies
  • 8.4.3. Online Pharmacies

Chapter 9. Global Bone Cancer Treatment Market, Regional Analysis

• 9.1. Bone Cancer Treatment Market, Regional Market Snapshot
• 9.2. North America Bone Cancer Treatment Market
  • 9.2.1. U.S. Bone Cancer Treatment Market
    • 9.2.1.1. Type breakdown estimates & forecasts, 2019-2029
    • 9.2.1.2. Drug Type breakdown estimates & forecasts, 2019-2029
    • 9.2.1.3. Distribution Channel breakdown estimates & forecasts, 2019-2029
  • 9.2.2. Canada Bone Cancer Treatment Market
• 9.3. Europe Bone Cancer Treatment Market Snapshot
  • 9.3.1. U.K. Bone Cancer Treatment Market
  • 9.3.2. Germany Bone Cancer Treatment Market
  • 9.3.3. France Bone Cancer Treatment Market
  • 9.3.4. Spain Bone Cancer Treatment Market
  • 9.3.5. Italy Bone Cancer Treatment Market
  • 9.3.6. Rest of Europe Bone Cancer Treatment Market
• 9.4. Asia-Pacific Bone Cancer Treatment Market Snapshot
  • 9.4.1. China Bone Cancer Treatment Market
  • 9.4.2. India Bone Cancer Treatment Market
  • 9.4.3. Japan Bone Cancer Treatment Market
  • 9.4.4. Australia Bone Cancer Treatment Market
  • 9.4.5. South Korea Bone Cancer Treatment Market
  • 9.4.6. Rest of Asia Pacific Bone Cancer Treatment Market
• 9.5. Latin America Bone Cancer Treatment Market Snapshot
  • 9.5.1. Brazil Bone Cancer Treatment Market
  • 9.5.2. Mexico Bone Cancer Treatment Market
  • 9.5.3. Rest of Latin America Bone Cancer Treatment Market
• 9.6. Rest of The World Bone Cancer Treatment Market

Chapter 10. Competitive Intelligence

• 10.1. Top Market Strategies
• 10.2. Company Profiles
  • 10.2.1. Advaxis Inc.
    • 10.2.1.1. Key Information
    • 10.2.1.2. Overview
    • 10.2.1.3. Financial (Subject to Data Availability)
    • 10.2.1.4. Product Summary
    • 10.2.1.5. Recent Developments
  • 10.2.2. Takeda Pharmaceutical Company Limited
  • 10.2.3. Cancervax, Inc
  • 10.2.4. Cellectar Biosciences, Inc
  • 10.2.5. Pfizer, Inc
  • 10.2.6. Isofol Medical Ab
  • 10.2.7. Gradalis Inc
  • 10.2.8. Hikma Pharmaceutical PLC
  • 10.2.9. QSAM Biosciences, Inc.
  • 10.2.10. Zentalis Pharmaceuticals

Chapter 11. Research Process

• 11.1. Research Process
  • 11.1.1. Data Mining
  • 11.1.2. Analysis
  • 11.1.3. Market Estimation
  • 11.1.4. Validation
  • 11.1.5. Publishing
• 11.2. Research Attributes
• 11.3. Research Assumption